Patient Safety Authority Logo

Skip navigation links
HOME
PATIENT SAFETY AUTHORITYExpand PATIENT SAFETY AUTHORITY
PA-PSRS and PASSKEYExpand PA-PSRS and PASSKEY
PATIENT SAFETY ADVISORIESExpand PATIENT SAFETY ADVISORIES
PATIENTS AND CONSUMERSExpand PATIENTS AND CONSUMERS
NEWS AND INFORMATIONExpand NEWS AND INFORMATION
EDUCATIONAL TOOLSExpand EDUCATIONAL TOOLS
AUTHORITY EVENTSExpand AUTHORITY EVENTS







ADDRESS:

Patient Safety Authority
333 Market Street
Lobby Level
Harrisburg, PA 17120


Phone: 717-346-0469
Fax: 717-346-1090


 
Advisory Banner
“Manager Spoke with RN Involved: Reviewed Policy No. 750”
Pa Patient Saf Advis 2008 Jun;5(2):63. 
 

The response says it all!

The following report was submitted through PA-PSRS (some information in this report has been altered to deidentify the facility):

The [infant] patient received 500 mg (100 ml) bag of Flagyl® instead of 27.3 mg (5.46 ml). The outer bag was labeled 27.3 mg/5.46 ml but the inner bag was labeled from the manufacturer [500 mg (100 ml)]. . . . RN used outer pharmacy label when verifying correct medication, correct patient, and correct dose. [RN] did not read manufacturer bag prior to hanging medication. . . . Manager spoke with RN involved: reviewed policy No. 750. . . .

Apparently, in the minds of administrators in this facility, the nurse (i.e., RN) had failed to either read or remember policy No. 750; had he or she done so, the error would not have occurred.

The patient safety analysts saw it differently, as follows:

A person can’t be expected to remember 750-plus policies.

The organization may believe that “following policies and procedures” is an effective strategy to prevent errors. Patient safety experts know that patient safety solutions that are expecting humans to ”be more careful,” such as “follow the five rights,” are ineffective system solutions.

The labeling was ambiguous, increasing the risks of an inadvertent human error.

The best way to avoid an overdose is to not deliver enough drug to the bedside to have an overdose. This medication error was due to the RN thinking he or she had to deliver the entire 100 ml. Had the nurse programmed an IV pump to deliver the correct amount, another error could have still resulted in the delivery of the full 100 ml overdose.

From a nursing perspective, having a pharmacy technician prepare the medication as a unit dose that is checked by a pharmacy and labeled with the total dose and mg/ml will allow the nurse to triple check the infusion rate against the order. Obviously, pharmacy needs to have its own systems in place to prevent the error. The pharmacy could also send the medication in a syringe pump that doesn’t allow large amounts of fluids to be administered.

The patient safety analysts believe a better solution would have been to deliver unit doses to the bedside, hopefully eliminating the need for every provider to remember policy No. 750 with every patient encounter to avoid an overdose.

 
 Browse by Topic
Navigation  



THE PENNSYLVANIA PATIENT SAFETY AUTHORITY AND ITS CONTRACTORS  
PSA LOGO The Pennsylvania Patient Safety Authority is an independent state agency created by Act 13 of 2002, the Medical Care Availability and Reduction of Error (“Mcare”) Act. Consistent with Act 13, ECRI Institute, as contractor for the Authority, is issuing this publication to advise medical facilities of immediate changes that can be instituted to reduce Serious Events and Incidents. For more information about the Pennsylvania Patient Safety Authority, see the Authority’s Web site at www.patientsafetyauthority.org .      
ECRI LOGO ECRI Institute, a nonprofit organization, dedicates itself to bringing the discipline of applied scientific research in healthcare to uncover the best approaches to improving patient care. As pioneers in this science for more than 40 years, ECRI Institute marries experience and independence with the objectivity of evidence-based research. More than 5,000 healthcare organizations worldwide rely on ECRI Institute’s expertise in patient safety improvement, risk and quality management, and healthcare processes, devices, procedures and drug technology.      

ISMP Logo The Institute for Safe Medication Practices (ISMP) is an independent, nonprofit organization dedicated solely to medication error prevention and safe medication use. ISMP provides recommendations for the safe use of medications to the healthcare community including healthcare professionals, government agencies, accrediting organizations, and consumers. ISMP’s efforts are built on a nonpunitive approach and systems-based solutions.      
 
©2012 Pennsylvania Patient Safety Authority                                                Home      Who We Are      Contact Us     Subscribe to Advisories and Press Releases   Site Map     Privacy Statement